Tokai Pharmaceuticals Inc (NASDAQ:TKAI) and Otic Pharma Ltd. announced that the two companies, together with the shareholders of Otic Pharma, have entered into …
Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced …
William Blair analyst Y. Katherine Xu remains on the sidelines with shares of Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today …
Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today reported …
Tokai Pharmaceuticals Inc (NASDAQ:TKAI) provided an update on its clinical development program evaluating galeterone in the treatment of men with metastatic castration-resistant prostate cancer …
Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally-driven diseases, today announced …
